 | • レポートコード：GIR-2104Z07257 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヒトインスリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒトインスリンの種類別市場規模（インスリンアナログ・バイオシミラー、ヒトインスリン生物製剤）、用途別市場規模（短時間作用型、中型作用型、長時間作用型、プレミックスインスリン）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヒトインスリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：B. Braun、Becton, Dickinson、Biocon、Biodel、ELI Lilly、Julphar、NOVO Nordisk、Sanofi、Wockhardt、Ypsomed ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：インスリンアナログ・バイオシミラー、ヒトインスリン生物製剤 ・用途別分析2016年-2026年：短時間作用型、中型作用型、長時間作用型、プレミックスインスリン ・ヒトインスリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヒトインスリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒトインスリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒトインスリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヒトインスリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Human Insulin size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Human Insulin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Human Insulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Insulin Analogs and Biosimilars
Human Insulin Biologics
Market segment by Application can be divided into
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
The key market players for global Human Insulin market are listed below:
B. Braun
Becton, Dickinson
Biocon
Biodel
ELI Lilly
Julphar
NOVO Nordisk
Sanofi
Wockhardt
Ypsomed
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Human Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Insulin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Insulin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Short acting
1.3.3 Intermediate acting
1.3.4 Long acting
1.3.5 Pre-mix Insulin
1.4 Global Human Insulin Market Size & Forecast
1.4.1 Global Human Insulin Sales in Value (2016-2026))
1.4.2 Global Human Insulin Sales in Volume (2016-2026)
1.4.3 Global Human Insulin Price by Type (2016-2026) & (USD/Dose)
1.5 Global Human Insulin Production Capacity Analysis
1.5.1 Global Human Insulin Total Production Capacity (2016-2026)
1.5.2 Global Human Insulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Insulin Market Drivers
1.6.2 Human Insulin Market Restraints
1.6.3 Human Insulin Trends Analysis
2 Manufacturers Profiles
2.1 B. Braun
2.1.1 B. Braun Details
2.1.2 B. Braun Major Business
2.1.3 B. Braun Human Insulin Product and Services
2.1.4 B. Braun Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Becton, Dickinson
2.2.1 Becton, Dickinson Details
2.2.2 Becton, Dickinson Major Business
2.2.3 Becton, Dickinson Human Insulin Product and Services
2.2.4 Becton, Dickinson Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Biocon
2.3.1 Biocon Details
2.3.2 Biocon Major Business
2.3.3 Biocon Human Insulin Product and Services
2.3.4 Biocon Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Biodel
2.4.1 Biodel Details
2.4.2 Biodel Major Business
2.4.3 Biodel Human Insulin Product and Services
2.4.4 Biodel Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 ELI Lilly
2.5.1 ELI Lilly Details
2.5.2 ELI Lilly Major Business
2.5.3 ELI Lilly Human Insulin Product and Services
2.5.4 ELI Lilly Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Julphar
2.6.1 Julphar Details
2.6.2 Julphar Major Business
2.6.3 Julphar Human Insulin Product and Services
2.6.4 Julphar Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 NOVO Nordisk
2.7.1 NOVO Nordisk Details
2.7.2 NOVO Nordisk Major Business
2.7.3 NOVO Nordisk Human Insulin Product and Services
2.7.4 NOVO Nordisk Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Human Insulin Product and Services
2.8.4 Sanofi Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Wockhardt
2.9.1 Wockhardt Details
2.9.2 Wockhardt Major Business
2.9.3 Wockhardt Human Insulin Product and Services
2.9.4 Wockhardt Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Ypsomed
2.10.1 Ypsomed Details
2.10.2 Ypsomed Major Business
2.10.3 Ypsomed Human Insulin Product and Services
2.10.4 Ypsomed Human Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Human Insulin Sales by Manufacturer
3.1 Global Human Insulin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Insulin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Insulin
3.4 Market Concentration Rate
3.4.1 Top 3 Human Insulin Manufacturer Market Share
3.4.2 Top 6 Human Insulin Manufacturer Market Share
3.5 Global Human Insulin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Insulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Insulin Market Size by Region
4.1.1 Global Human Insulin Sales in Volume by Region (2016-2026)
4.1.2 Global Human Insulin Revenue by Region (2016-2026)
4.2 North America Human Insulin Revenue (2016-2026)
4.3 Europe Human Insulin Revenue (2016-2026)
4.4 Asia-Pacific Human Insulin Revenue (2016-2026)
4.5 South America Human Insulin Revenue (2016-2026)
4.6 Middle East and Africa Human Insulin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Insulin Sales in Volume by Type (2016-2026)
5.2 Global Human Insulin Revenue by Type (2016-2026)
5.3 Global Human Insulin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Insulin Sales in Volume by Application (2016-2026)
6.2 Global Human Insulin Revenue by Application (2016-2026)
6.3 Global Human Insulin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Insulin Sales by Type (2016-2026)
7.2 North America Human Insulin Sales by Application (2016-2026)
7.3 North America Human Insulin Market Size by Country
7.3.1 North America Human Insulin Sales in Volume by Country (2016-2026)
7.3.2 North America Human Insulin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Insulin Sales by Type (2016-2026)
8.2 Europe Human Insulin Sales by Application (2016-2026)
8.3 Europe Human Insulin Market Size by Country
8.3.1 Europe Human Insulin Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Insulin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Insulin Sales by Type (2016-2026)
9.2 Asia-Pacific Human Insulin Sales by Application (2016-2026)
9.3 Asia-Pacific Human Insulin Market Size by Region
9.3.1 Asia-Pacific Human Insulin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Insulin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Insulin Sales by Type (2016-2026)
10.2 South America Human Insulin Sales by Application (2016-2026)
10.3 South America Human Insulin Market Size by Country
10.3.1 South America Human Insulin Sales in Volume by Country (2016-2026)
10.3.2 South America Human Insulin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Insulin Sales by Type (2016-2026)
11.2 Middle East & Africa Human Insulin Sales by Application (2016-2026)
11.3 Middle East & Africa Human Insulin Market Size by Country
11.3.1 Middle East & Africa Human Insulin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Insulin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Insulin Typical Distributors
12.3 Human Insulin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Human Insulin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Insulin Revenue by Application, (USD Million), 2021-2026
Table 3. B. Braun Basic Information, Manufacturing Base and Competitors
Table 4. B. Braun Major Business
Table 5. B. Braun Human Insulin Product and Services
Table 6. B. Braun Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Becton, Dickinson Basic Information, Manufacturing Base and Competitors
Table 8. Becton, Dickinson Major Business
Table 9. Becton, Dickinson Human Insulin Product and Services
Table 10. Becton, Dickinson Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biocon Basic Information, Manufacturing Base and Competitors
Table 12. Biocon Major Business
Table 13. Biocon Human Insulin Product and Services
Table 14. Biocon Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biodel Basic Information, Manufacturing Base and Competitors
Table 16. Biodel Major Business
Table 17. Biodel Human Insulin Product and Services
Table 18. Biodel Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. ELI Lilly Basic Information, Manufacturing Base and Competitors
Table 20. ELI Lilly Major Business
Table 21. ELI Lilly Human Insulin Product and Services
Table 22. ELI Lilly Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Julphar Basic Information, Manufacturing Base and Competitors
Table 24. Julphar Major Business
Table 25. Julphar Human Insulin Product and Services
Table 26. Julphar Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. NOVO Nordisk Basic Information, Manufacturing Base and Competitors
Table 28. NOVO Nordisk Major Business
Table 29. NOVO Nordisk Human Insulin Product and Services
Table 30. NOVO Nordisk Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Human Insulin Product and Services
Table 34. Sanofi Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 36. Wockhardt Major Business
Table 37. Wockhardt Human Insulin Product and Services
Table 38. Wockhardt Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Ypsomed Basic Information, Manufacturing Base and Competitors
Table 40. Ypsomed Major Business
Table 41. Ypsomed Human Insulin Product and Services
Table 42. Ypsomed Human Insulin Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Human Insulin Sales by Manufacturer (2019-2021e) & (K Doses)
Table 44. Global Human Insulin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Human Insulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Human Insulin Production Capacity by Company, (K Doses): 2020 VS 2021
Table 47. Head Office and Human Insulin Production Site of Key Manufacturer
Table 48. Global Human Insulin Sales by Region (2016-2021e) & (K Doses)
Table 49. Global Human Insulin Sales by Region (2021-2026) & (K Doses)
Table 50. Global Human Insulin Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Human Insulin Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Human Insulin Sales by Type (2016-2021e) & (K Doses)
Table 53. Global Human Insulin Sales by Type (2021-2026) & (K Doses)
Table 54. Global Human Insulin Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Human Insulin Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Human Insulin Price by Type (2016-2021e) & (USD/Dose)
Table 57. Global Human Insulin Price by Type (2021-2026) & (USD/Dose)
Table 58. Global Human Insulin Sales by Application (2016-2021e) & (K Doses)
Table 59. Global Human Insulin Sales by Application (2021-2026) & (K Doses)
Table 60. Global Human Insulin Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Human Insulin Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Human Insulin Price by Application (2016-2021e) & (USD/Dose)
Table 63. Global Human Insulin Price by Application (2021-2026) & (USD/Dose)
Table 64. North America Human Insulin Sales by Country (2016-2021e) & (K Doses)
Table 65. North America Human Insulin Sales by Country (2021-2026) & (K Doses)
Table 66. North America Human Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Human Insulin Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Human Insulin Sales by Type (2016-2021e) & (K Doses)
Table 69. North America Human Insulin Sales by Type (2021-2026) & (K Doses)
Table 70. North America Human Insulin Sales by Application (2016-2021e) & (K Doses)
Table 71. North America Human Insulin Sales by Application (2021-2026) & (K Doses)
Table 72. Europe Human Insulin Sales by Country (2016-2021e) & (K Doses)
Table 73. Europe Human Insulin Sales by Country (2021-2026) & (K Doses)
Table 74. Europe Human Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Human Insulin Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Human Insulin Sales by Type (2016-2021e) & (K Doses)
Table 77. Europe Human Insulin Sales by Type (2021-2026) & (K Doses)
Table 78. Europe Human Insulin Sales by Application (2016-2021e) & (K Doses)
Table 79. Europe Human Insulin Sales by Application (2021-2026) & (K Doses)
Table 80. Asia-Pacific Human Insulin Sales by Region (2016-2021e) & (K Doses)
Table 81. Asia-Pacific Human Insulin Sales by Region (2021-2026) & (K Doses)
Table 82. Asia-Pacific Human Insulin Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Human Insulin Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Human Insulin Sales by Type (2016-2021e) & (K Doses)
Table 85. Asia-Pacific Human Insulin Sales by Type (2021-2026) & (K Doses)
Table 86. Asia-Pacific Human Insulin Sales by Application (2016-2021e) & (K Doses)
Table 87. Asia-Pacific Human Insulin Sales by Application (2021-2026) & (K Doses)
Table 88. South America Human Insulin Sales by Country (2016-2021e) & (K Doses)
Table 89. South America Human Insulin Sales by Country (2021-2026) & (K Doses)
Table 90. South America Human Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Human Insulin Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Human Insulin Sales by Type (2016-2021e) & (K Doses)
Table 93. South America Human Insulin Sales by Type (2021-2026) & (K Doses)
Table 94. South America Human Insulin Sales by Application (2016-2021e) & (K Doses)
Table 95. South America Human Insulin Sales by Application (2021-2026) & (K Doses)
Table 96. Middle East & Africa Human Insulin Sales by Country (2016-2021e) & (K Doses)
Table 97. Middle East & Africa Human Insulin Sales by Country (2021-2026) & (K Doses)
Table 98. Middle East & Africa Human Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Human Insulin Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Human Insulin Sales by Type (2016-2021e) & (K Doses)
Table 101. Middle East & Africa Human Insulin Sales by Type (2021-2026) & (K Doses)
Table 102. Middle East & Africa Human Insulin Sales by Application (2016-2021e) & (K Doses)
Table 103. Middle East & Africa Human Insulin Sales by Application (2021-2026) & (K Doses)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Human Insulin Typical Distributors
Table 107. Human Insulin Typical Customers
List of Figures
Figure 1. Human Insulin Picture
Figure 2. Global Human Insulin Sales Market Share by Type in 2020
Figure 3. Insulin Analogs and Biosimilars
Figure 4. Human Insulin Biologics
Figure 5. Global Human Insulin Sales Market Share by Application in 2020
Figure 6. Short acting
Figure 7. Intermediate acting
Figure 8. Long acting
Figure 9. Pre-mix Insulin
Figure 10. Global Human Insulin Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 11. Global Human Insulin Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Human Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Human Insulin Sales (2016-2026) & (K Doses)
Figure 32. Global Human Insulin Production Capacity (2016-2026) & (K Doses)
Figure 33. Global Human Insulin Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Human Insulin Market Drivers
Figure 35. Human Insulin Market Restraints
Figure 36. Human Insulin Market Trends
Figure 37. Global Human Insulin Sales Market Share by Manufacturer in 2020
Figure 38. Global Human Insulin Revenue Market Share by Manufacturer in 2020
Figure 39. Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Human Insulin Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Human Insulin Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Human Insulin Sales Market Share by Region (2016-2026)
Figure 43. Global Human Insulin Revenue Market Share by Region (2016-2026)
Figure 44. North America Human Insulin Revenue (2016-2026) & (USD Million)
Figure 45. Europe Human Insulin Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Human Insulin Revenue (2016-2026) & (USD Million)
Figure 47. South America Human Insulin Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Human Insulin Revenue (2016-2026) & (USD Million)
Figure 49. Global Human Insulin Sales Market Share by Type (2016-2026)
Figure 50. Global Human Insulin Revenue Market Share by Type (2016-2026)
Figure 51. Global Human Insulin Price by Type (2016-2026) & (USD/Dose)
Figure 52. Global Human Insulin Sales Market Share by Application (2016-2026)
Figure 53. Global Human Insulin Revenue Market Share by Application (2016-2026)
Figure 54. Global Human Insulin Price by Application (2016-2026) & (USD/Dose)
Figure 55. North America Human Insulin Sales Market Share by Country (2016-2026)
Figure 56. North America Human Insulin Revenue Market Share by Country (2016-2026)
Figure 57. North America Human Insulin Sales Market Share by Type (2016-2026)
Figure 58. North America Human Insulin Sales Market Share by Application (2016-2026)
Figure 59. Europe Human Insulin Sales Market Share by Country (2016-2026)
Figure 60. Europe Human Insulin Revenue Market Share by Country (2016-2026)
Figure 61. Europe Human Insulin Sales Market Share by Type (2016-2026)
Figure 62. Europe Human Insulin Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Human Insulin Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Human Insulin Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Human Insulin Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Human Insulin Sales Market Share by Application (2016-2026)
Figure 67. South America Human Insulin Sales Market Share by Country (2016-2026)
Figure 68. South America Human Insulin Revenue Market Share by Country (2016-2026)
Figure 69. South America Human Insulin Sales Market Share by Type (2016-2026)
Figure 70. South America Human Insulin Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Human Insulin Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Human Insulin Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Human Insulin Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Human Insulin Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のCISインスリン市場規模・現状・予測（2021年-2027年） Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body. Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government. Market Analysis and…- 速効型インスリンの世界市場2020年：分析と予測（～2025年） This report describes the global market size of Rapid-acting Insulin from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 2015 to …
- 世界のインスリンパッチ式ポンプ市場 2021：企業別、地域別、種類・用途別 The Insulin Patch Pump market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の獣医用インスリン治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Veterinary Insulin Drugs Market The global Veterinary Insulin Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界のインスリンポンプ付属品市場 2021：企業別、地域別、種類・用途別 The Insulin pump Accessories market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…